Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy
JACC: Clinical Electrophysiology · 2026
DOI: 10.1016/j.jacep.2025.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026. Verfasst von Juwon Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Mental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The incidence and prognostic implications of mental disorders after implantable cardioverter-defibrillator (ICD) therapy remain underexplored. OBJECTIVES: This study sought to investigate the incidence of newly diagnosed mental disorders after ICD implantation compared with the incidence in matched non-ICD control subjects and to evaluate the impact of these disorders on prognosis. METHODS: Using the Korean National Health Insurance Service database, 6,356 patients with an ICD and 17,664 propensity score-matched control subjects were selected between 2010 and 2020. In the ICD group, long-term prognosis was compared between patients with and without mental disorders newly diagnosed postimplantation. RESULTS: The 10-year cumulative incidence of newly diagnosed mental disorders was 37.3% in ICD patients, significantly higher than in the matched control subjects (34.5%; HR: 1.21; 95% CI: 1.14-1.29). The most frequent mental disorders were depressive disorder (18.4%), insomnia (16.8%), and anxiety disorder (5.8%). Among ICD patients, newly diagnosed mental disorders adversely affected long-term prognosis, with significantly higher all-cause mortality (HR: 2.00; 95% CI: 1.76-2.28), cardiac mortality (HR: 1.83; 95% CI: 1.53-2.18), severe heart failure events (HR: 2.12; 95% CI: 1.54-2.93), and any-cause readmissions (HR: 1.65; 95% CI: 1.50-1.82) compared with those without mental disorders. In particular, schizophrenia spectrum disorders and mental disorders diagnosed early (within 2.8 years' postimplantation) were strongly associated with worse clinical outcomes. The adverse effect of mental disorders on mortality was more pronounced in patients with atrial fibrillation than in those without atrial fibrillation (Pinteraction = 0.04). CONCLUSIONS: Evidence-based ICD implantation, proactive screening, and timely management of mental disorders may mitigate adverse outcomes associated with ICD therapy and mental disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Psychiatry, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-Do, South Korea.
- Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea.
- Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, South Korea. Ele…
- Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: orthovics@skku.edu.
Zitieren
APA
Kim, J., Kim, H., Kim, H., Kim, J. Y., Park, K. M., On, Y. K., Kang, D., & Park, S. J. (2026). Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2025.09.006
Vancouver
Kim J, Kim H, Kim H, Kim JY, Park KM, On YK, et al. Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2025.09.006
BibTeX
@article{Kim2026,
author = {Kim, Juwon and Kim, Hyewon and Kim, Hyunsoo and Kim, Ju Youn and Park, Kyoung-Min and On, Young Keun and Kang, Danbee and Park, Seung-Jung},
title = {Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
doi = {10.1016/j.jacep.2025.09.006}
}
EUVIMED